Pulmonary sepsis, Visual impairment, Prostatomegaly +2
Drugs: BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM
- Safetyreportversion
- 1
- Safetyreportid
- 27325202
- Primarysourcecountry
- US
- Occurcountry
- US
- Transmissiondateformat
- 102
- Transmissiondate
- 20261010
- Reporttype
- 2
- Serious
- 1
- Seriousnessdeath
- 2
- Seriousnesslifethreatening
- 2
- Seriousnesshospitalization
- 2
- Seriousnessdisabling
- 2
- Seriousnesscongenitalanomali
- 2
- Seriousnessother
- 1
- Receivedateformat
- 102
- Receivedate
- 20260930
- Receiptdateformat
- 102
- Receiptdate
- 20260930
- Fulfillexpeditecriteria
- 1
- Companynumb
- US-AstraZeneca-CH-01208868A
- Primarysource
- Reportercountry
- US
- Qualification
- 5
- Sender
- Sendertype
- 6
- Senderorganization
- ALEXION PHARMACEUTICALS
- Receiver
- Receivertype
- 6
- Receiverorganization
- FDA
- Patient
- Patientagegroup
- 6
- Patientsex
- 1
- Reaction
- Reactionmeddraversionpt
- 29.0
- Reactionmeddrapt
- Pulmonary sepsis
- Reactionoutcome
- 6
- Reactionmeddraversionpt
- 29.0
- Reactionmeddrapt
- Visual impairment
- Reactionoutcome
- 6
- Reactionmeddraversionpt
- 29.0
- Reactionmeddrapt
- Prostatomegaly
- Reactionoutcome
- 6
- Reactionmeddraversionpt
- 29.0
- Reactionmeddrapt
- Confusional state
- Reactionoutcome
- 6
- Reactionmeddraversionpt
- 29.0
- Reactionmeddrapt
- Feeling abnormal
- Reactionoutcome
- 6
- Drug
- Drugcharacterization
- 1
- Medicinalproduct
- BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM
- Drugbatchnumb
- Unknown
- Drugauthorizationnumb
- 212122
- Drugseparatedosagenumb
- 1
- Drugadministrationroute
- 065
- Actiondrug
- 4
- Drugrecurreadministration
- 3
- Activesubstance
- Activesubstancename
- BUDESONIDE\FORMOTEROL\GLYCOPYRRONIUM
